{
  "@context": "https://agentflare.org/schema",
  "type": "NewsArticle",
  "tier": "L2-full",
  "title": "Earnings News, Oct 28, 2026: Microsoft to report fiscal Q1 on Oct. 28 with first Azure dollar revenue figure",
  "description": "Microsoft reports fiscal first-quarter results after the close on Oct. 28 under a new two-segment structure, with Wall Street expecting EPS of $4.27 on…",
  "canonical": "https://agentflare.org/news/2026-10-28-earnings.html",
  "category": "news",
  "updated": "2026-10-28",
  "generated_at": "2026-10-28T00:37:01.991Z",
  "facts": [
    {
      "label": "Desk",
      "value": "Earnings"
    },
    {
      "label": "Date",
      "value": "Wed, Oct 28, 2026"
    },
    {
      "label": "Stories",
      "value": "5"
    },
    {
      "label": "Outlets cited",
      "value": "10"
    },
    {
      "label": "Items screened",
      "value": "12"
    },
    {
      "label": "Freshness",
      "value": "last 48h"
    }
  ],
  "data": {
    "date": "2026-10-28",
    "cluster": "earnings",
    "headline": "Microsoft to report fiscal Q1 on Oct. 28 with first Azure dollar revenue figure",
    "dek": "Microsoft reports fiscal first-quarter results after the close on Oct. 28 under a new two-segment structure, with Wall Street expecting EPS of $4.27 on revenue of $90.6 billion.",
    "generated_at": "2026-10-28T00:42:17.951Z",
    "freshness_hours": 48,
    "stories": [
      {
        "title": "Microsoft Q1 report brings new segments and first Azure revenue figure",
        "summary": "Microsoft reports fiscal first-quarter results after the bell on Oct. 28, its first under a two-segment structure: Agents and Infra, and Devices and Consumer. It will also give quarterly dollar revenue for Azure for the first time. Bloomberg consensus is EPS of $4.27 on revenue of $90.6 billion, against $4.13 and $77.6 billion a year earlier. Agents and Infra is expected to rise 22.5% to $75.6 billion, with Azure at $32.2 billion. Devices and Consumer is seen down 6% to $15 billion. Capex is expected above $45.9 billion, and remaining performance obligations at $705.6 billion. Microsoft also offered buyouts to upward of 60,000 eligible employees. Shares have climbed about 35% since July.",
        "why": "The first Azure dollar figure and AI-driven capex and backlog numbers will test a stock that has rallied sharply since July.",
        "sources": [
          {
            "id": "S3",
            "title": "Microsoft to report Q1 earnings with Wall Street looking for further Azure growth",
            "url": "https://finance.yahoo.com/technology/article/microsoft-to-report-q1-earnings-with-wall-street-looking-for-further-azure-growth-160835128.html",
            "publisher": "Yahoo Finance",
            "published": "2026-10-27T16:08:35.000Z"
          },
          {
            "id": "S4",
            "title": "Microsoft earnings will look funky — but an elusive number is finally arriving",
            "url": "https://www.marketwatch.com/story/microsoft-earnings-will-look-funky-but-an-elusive-number-is-finally-arriving-73236a94",
            "publisher": "MarketWatch",
            "published": "2026-10-27T14:53:00.000Z"
          },
          {
            "id": "S11",
            "title": "Microsoft's Stock May Fall Sharply Following Quarterly Results (NASDAQ:MSFT)",
            "url": "https://seekingalpha.com/article/4957544-microsofts-stock-may-fall-sharply-following-quarterly-results",
            "publisher": "Seeking Alpha",
            "published": "2026-10-26T17:06:07.000Z"
          }
        ],
        "entities": [
          "MSFT"
        ]
      },
      {
        "title": "Palantir heads into Nov. 2 earnings near highs as Rosenblatt lifts target",
        "summary": "Palantir reports third-quarter results on Nov. 2 after the close. Analysts estimate EPS of 41 cents on revenue of $2.18 billion, and options pricing implies a 12% move either way. Rosenblatt raised its price target to $260 from $225, implying 31% upside from the Oct. 26 close, citing checks that point to strong growth. LSEG data shows 25 of 34 analysts rate the stock buy or strong buy. In the second quarter, U.S. commercial revenue grew 149% to $764 million, and shares jumped 29.5% after that report. Investors will watch whether full-year guidance, previously raised to 82% revenue growth, goes up again.",
        "why": "A 12% implied move and a stock near its 52-week high leave little room for a guidance disappointment.",
        "sources": [
          {
            "id": "S2",
            "title": "Palantir Put Strategy Aims To Cash In On Potential Earnings Volatility",
            "url": "https://www.investors.com/research/options/palantir-stock-pltr-software-tech-options-trade-strategy-markets-investing/",
            "publisher": "Investor's Business Daily",
            "published": "2026-10-27T16:41:48.000Z"
          },
          {
            "id": "S7",
            "title": "Palantir Stock Within 7% of Its 52-Week High as Earnings and Target Hikes Fuel Buzz",
            "url": "https://www.benzinga.com/trading-ideas/movers/26/10/62617607/palantir-stock-within-7-of-its-52-week-high-as-earnings-and-target-hikes-fuel-buzz",
            "publisher": "Benzinga",
            "published": "2026-10-27T12:53:07.000Z"
          },
          {
            "id": "S8",
            "title": "Buy Palantir ahead of earnings, says Rosenblatt",
            "url": "https://www.cnbc.com/2026/10/27/palantir-rosenblatt-price-target-earnings.html",
            "publisher": "CNBC",
            "published": "2026-10-27T11:20:08.000Z"
          }
        ],
        "entities": [
          "PLTR"
        ]
      },
      {
        "title": "SoFi posts record third quarter and raises 2026 guidance",
        "summary": "SoFi reported third-quarter 2026 results on Oct. 27. Adjusted net revenue rose 44% to a record $1.4 billion, and adjusted EBITDA rose 70% to a record $470 million. Adjusted net income was $243 million, or $0.18 per share. Members grew 35% to 17.1 million, and products rose 44% to 26.7 million. The company lifted 2026 guidance to $5.04 billion in adjusted net revenue and $1.66 billion in adjusted EBITDA. It also introduced a 2027 outlook of $6.4 billion in adjusted net revenue, $2.24 billion in adjusted EBITDA and $0.90 of EPS.",
        "why": "A guidance raise plus a first 2027 outlook gives investors a multi-year earnings path for the fintech lender.",
        "sources": [
          {
            "id": "S9",
            "title": "SoFi Technologies, Inc. (SOFI) - SoFi Reports Third Quarter 2026 with Record Net Revenue of $1.4 Billion, Net Income of $241 Million and Raises Full-Year Guidance",
            "url": "https://investors.sofi.com/news/news-details/2026/SoFi-Reports-Third-Quarter-2026-with-Record-Net-Revenue-of-1-4-Billion-Net-Income-of-241-Million-and-Raises-Full-Year-Guidance/default.aspx",
            "publisher": "investors.sofi.com",
            "published": "2026-10-27T10:00:00.000Z"
          }
        ],
        "entities": [
          "SOFI"
        ]
      },
      {
        "title": "Big pharma earnings week: Lilly, Merck, AbbVie, Gilead and Bristol Myers",
        "summary": "Bristol Myers, Eli Lilly, Merck, AbbVie and Gilead Sciences are all scheduled to report quarterly results this week. As of Oct. 21, 11.7% of Medical sector companies had reported, and 85.7% of them topped earnings and sales estimates. Sector third-quarter earnings are projected to fall 1.3% while sales rise 4.5%. Bristol Myers' consensus is $12.56 billion in sales and $1.28 per share. Lilly declared a fourth-quarter dividend of $1.73 per share on Oct. 26 and closed at $1,279.14; its second-quarter revenue rose 48%, and management had raised annual revenue guidance.",
        "why": "Results from these bellwethers will shape the sector's earnings picture, with Lilly's volume-driven growth and guidance in focus.",
        "sources": [
          {
            "id": "S5",
            "title": "What's in Store for These 5 Drug/Biotech Stocks in Q3 Earnings?",
            "url": "https://www.tradingview.com/news/zacks:3d4542e71094b:0-what-s-in-store-for-these-5-drug-biotech-stocks-in-q3-earnings/",
            "publisher": "TradingView",
            "published": "2026-10-27T13:47:00.000Z"
          },
          {
            "id": "S10",
            "title": "Eli Lilly and Company (NYSE:LLY) Extends Clinical Evidence as Medicine Sales Support Higher Guidance",
            "url": "https://kalkine.com.au/news/healthcare/eli-lilly-and-company-nyselly-extends-clinical-evidence-as-medicine-sales-support-higher-guidance",
            "publisher": "Kalkine",
            "published": "2026-10-27T06:36:00.000Z"
          }
        ],
        "entities": [
          "LLY"
        ]
      },
      {
        "title": "UnitedHealth raises guidance a third time as medical costs ease",
        "summary": "UnitedHealth's third-quarter report showed profit rising sharply, adjusted earnings per share well ahead of consensus and another increase to full-year guidance, the third of the year. Revenue was roughly flat from a year earlier as the insurer shed less profitable members. The medical care ratio improved meaningfully, helped by pricing discipline and benefit design changes, though analysts note a reserve release flattered the headline figure. The operating cost ratio also declined. Operating cash flow exceeded net income.",
        "why": "Margin repair at the largest U.S. health insurer signals easing cost pressure, though reserve releases mean underlying gains are smaller than reported.",
        "sources": [
          {
            "id": "S12",
            "title": "UnitedHealth Group (NYSE:UNH) Margin Repair Drives Third Guidance Raise as Medical Costs Ease",
            "url": "https://kalkinemedia.com/us/stocks/healthcare/unitedhealth-group-nyseunh-margin-repair-drives-third-guidance-raise-as-medical-costs-ease",
            "publisher": "Kalkine Media",
            "published": "2026-10-26T13:33:00.000Z"
          }
        ],
        "entities": [
          "UNH"
        ]
      }
    ],
    "market": [
      {
        "id": "JPM",
        "kind": "equity",
        "last": 334.04,
        "asOf": "2026-10-26",
        "d1": 0.7419024066590374,
        "d30": -2.629277677374215,
        "series": [
          352.49,
          348.92,
          349.31,
          349.67,
          352.04,
          340,
          337.53,
          338.56,
          343.06,
          336.59,
          334.98,
          330.83,
          333.18,
          332.38,
          332.38,
          331.28,
          329.58,
          331.42,
          332.99,
          334.3,
          331.43,
          335.28,
          335.53,
          339.72,
          333.53,
          335.26,
          335.19,
          336.54,
          331.58,
          334.04
        ]
      },
      {
        "id": "GS",
        "kind": "equity",
        "last": 893.28,
        "asOf": "2026-10-26",
        "d1": 2.00986661794263,
        "d30": -4.5079908065636936,
        "series": [
          976.67,
          937.98,
          951.47,
          942,
          959.39,
          949.49,
          936.36,
          923.29,
          935.45,
          916.28,
          916.24,
          900.36,
          896.67,
          902.56,
          893.46,
          897.18,
          887.21,
          882.59,
          895.32,
          893.95,
          891.91,
          878.72,
          891.28,
          881.26,
          875.78,
          884.81,
          904.72,
          891.3,
          875.68,
          893.28
        ]
      },
      {
        "id": "UNH",
        "kind": "equity",
        "last": 410.7,
        "asOf": "2026-10-26",
        "d1": -1.7675620081800538,
        "d30": 9.057595793834148,
        "series": [
          375.93,
          375.26,
          375.21,
          376.9,
          377.56,
          372.95,
          371.29,
          375.01,
          376.59,
          377.83,
          374.94,
          367.08,
          365.2,
          371.9,
          378.58,
          376.32,
          375.98,
          370.95,
          379.3,
          378.52,
          377.76,
          395.62,
          406.67,
          401.43,
          406.88,
          419.26,
          417,
          424.98,
          418.09,
          410.7
        ]
      },
      {
        "id": "PLTR",
        "kind": "equity",
        "last": 198.84,
        "asOf": "2026-10-26",
        "d1": 1.0622617534942838,
        "d30": 4.834712922444254,
        "series": [
          172.56,
          174.34,
          176.24,
          177.64,
          183.09,
          184.99,
          191.79,
          192.59,
          189.67,
          187.48,
          186.97,
          187.05,
          190.04,
          188.75,
          189.4,
          192.07,
          194.12,
          198.78,
          209.05,
          209,
          208.67,
          200.97,
          200.5,
          186.03,
          194.15,
          192.6,
          201.72,
          196.19,
          196.75,
          198.84
        ]
      },
      {
        "id": "MSFT",
        "kind": "equity",
        "last": 532.6,
        "asOf": "2026-10-26",
        "d1": 1.5423919467693719,
        "d30": 3.1830598446248457,
        "series": [
          497.12,
          490.3,
          497.75,
          493.78,
          501.61,
          498,
          500.59,
          497.93,
          516.17,
          509.22,
          508.96,
          512.9,
          512.8,
          517.53,
          525.18,
          529.3,
          529.76,
          522.61,
          535.07,
          541.15,
          543.45,
          533.69,
          539.44,
          529.05,
          533.52,
          531.87,
          532.95,
          521.08,
          524.51,
          532.6
        ]
      },
      {
        "id": "LLY",
        "kind": "equity",
        "last": 1279.14,
        "asOf": "2026-10-26",
        "d1": 0.4460289290594179,
        "d30": 8.084768390989138,
        "series": [
          1136.11,
          1137.82,
          1152.44,
          1152.93,
          1164.89,
          1170.14,
          1150.99,
          1181.89,
          1183.46,
          1184.78,
          1184.63,
          1157.08,
          1149.85,
          1142.85,
          1143.12,
          1157.49,
          1188.72,
          1169.6,
          1179.27,
          1182.62,
          1166.51,
          1208.74,
          1251.61,
          1257.03,
          1240.34,
          1283.66,
          1270.75,
          1306.69,
          1273.46,
          1279.14
        ]
      },
      {
        "id": "SOFI",
        "kind": "equity",
        "last": 14.46,
        "asOf": "2026-10-26",
        "d1": -1.09439124487003,
        "d30": -12.786489746682737,
        "series": [
          17.07,
          16.84,
          16.73,
          16.96,
          16.97,
          17.16,
          16.55,
          16.8,
          16.58,
          15.93,
          15.91,
          15.72,
          15.84,
          15.77,
          15.92,
          15.76,
          15.66,
          15.61,
          15.8,
          15.23,
          15.24,
          14.22,
          15.09,
          14.55,
          14.3,
          14.68,
          14.9,
          14.77,
          14.62,
          14.46
        ]
      }
    ],
    "policy_rates": [],
    "prediction_markets": [],
    "watch": [
      {
        "text": "Microsoft reports fiscal first-quarter results after the market close on Oct. 28, including its first quarterly Azure revenue figure.",
        "sources": [
          "S3",
          "S4"
        ]
      },
      {
        "text": "Palantir reports third-quarter results on Nov. 2 after the close; options imply a 12% move in either direction.",
        "sources": [
          "S2",
          "S7"
        ]
      },
      {
        "text": "Conduent reports third-quarter 2026 results on Nov. 5 after market close, with a conference call at 4:30 p.m. ET.",
        "sources": [
          "S6"
        ]
      }
    ],
    "takeaways": [
      "Microsoft's Oct. 28 report brings new segments, a first Azure dollar figure, and consensus EPS of $4.27 on $90.6 billion revenue.",
      "Palantir's Nov. 2 report carries an options-implied 12% move, with Rosenblatt at a $260 target.",
      "SoFi raised 2026 guidance to $5.04 billion adjusted net revenue and issued a 2027 outlook."
    ],
    "faq": [
      {
        "q": "When does Microsoft report earnings and what is expected?",
        "a": "Microsoft reports fiscal first-quarter results after the close on Oct. 28. Bloomberg consensus calls for EPS of $4.27 on revenue of $90.6 billion, versus $4.13 and $77.6 billion a year earlier."
      },
      {
        "q": "What is new in Microsoft's reporting this quarter?",
        "a": "Microsoft moves to two segments, Agents and Infra, and Devices and Consumer, and will disclose quarterly dollar revenue for Azure for the first time. Azure is expected at $32.2 billion."
      },
      {
        "q": "When does Palantir report and how much move is priced in?",
        "a": "Palantir reports third-quarter results on Nov. 2 after the market close. Options are pricing in a 12% move in either direction, and analysts estimate EPS of 41 cents on $2.18 billion revenue."
      }
    ],
    "count": 5,
    "items": [
      {
        "title": "Visa Fiscal Fourth Quarter and Full-Year 2026 Financial Results",
        "url": "https://finance.yahoo.com/markets/stocks/articles/visa-fiscal-fourth-quarter-full-200500032.html",
        "source": "finance.yahoo.com",
        "date": "Tue, 27 Oct 2026 19:00:00 GMT",
        "tickers": [],
        "iso": "2026-10-27T19:00:00.000Z"
      },
      {
        "title": "Palantir Put Strategy Aims To Cash In On Potential Earnings Volatility",
        "url": "https://www.investors.com/research/options/palantir-stock-pltr-software-tech-options-trade-strategy-markets-investing/",
        "source": "Investor's Business Daily",
        "date": "2026-10-27T16:41:48+00:00",
        "tickers": [
          "PLTR"
        ],
        "iso": "2026-10-27T16:41:48.000Z"
      },
      {
        "title": "Microsoft to report Q1 earnings with Wall Street looking for further Azure growth",
        "url": "https://finance.yahoo.com/technology/article/microsoft-to-report-q1-earnings-with-wall-street-looking-for-further-azure-growth-160835128.html",
        "source": "Yahoo Finance",
        "date": "2026-10-27T16:08:35+00:00",
        "tickers": [
          "MSFT"
        ],
        "iso": "2026-10-27T16:08:35.000Z"
      },
      {
        "title": "Microsoft earnings will look funky — but an elusive number is finally arriving",
        "url": "https://www.marketwatch.com/story/microsoft-earnings-will-look-funky-but-an-elusive-number-is-finally-arriving-73236a94",
        "source": "MarketWatch",
        "date": "2026-10-27T14:53:00+00:00",
        "tickers": [
          "MSFT"
        ],
        "iso": "2026-10-27T14:53:00.000Z"
      },
      {
        "title": "What's in Store for These 5 Drug/Biotech Stocks in Q3 Earnings?",
        "url": "https://www.tradingview.com/news/zacks:3d4542e71094b:0-what-s-in-store-for-these-5-drug-biotech-stocks-in-q3-earnings/",
        "source": "TradingView",
        "date": "2026-10-27T13:47:00+00:00",
        "tickers": [
          "LLY"
        ],
        "iso": "2026-10-27T13:47:00.000Z"
      },
      {
        "title": "Conduent to Report Third-Quarter 2026 Financial Results on November 5, 2026",
        "url": "https://www.news.conduent.com/news/conduent-to-report-third-quarter-2026-financial-results-on-november-5-2026",
        "source": "news.conduent.com",
        "date": "Tue, 27 Oct 2026 13:00:00 GMT",
        "tickers": [],
        "iso": "2026-10-27T13:00:00.000Z"
      },
      {
        "title": "Palantir Stock Within 7% of Its 52-Week High as Earnings and Target Hikes Fuel Buzz",
        "url": "https://www.benzinga.com/trading-ideas/movers/26/10/62617607/palantir-stock-within-7-of-its-52-week-high-as-earnings-and-target-hikes-fuel-buzz",
        "source": "Benzinga",
        "date": "2026-10-27T12:53:07+00:00",
        "tickers": [
          "PLTR"
        ],
        "iso": "2026-10-27T12:53:07.000Z"
      },
      {
        "title": "Buy Palantir ahead of earnings, says Rosenblatt",
        "url": "https://www.cnbc.com/2026/10/27/palantir-rosenblatt-price-target-earnings.html",
        "source": "CNBC",
        "date": "2026-10-27T11:20:08+00:00",
        "tickers": [
          "PLTR"
        ],
        "iso": "2026-10-27T11:20:08.000Z"
      },
      {
        "title": "SoFi Technologies, Inc. (SOFI) - SoFi Reports Third Quarter 2026 with Record Net Revenue of $1.4 Billion, Net Income of $241 Million and Raises Full-Year Guidance",
        "url": "https://investors.sofi.com/news/news-details/2026/SoFi-Reports-Third-Quarter-2026-with-Record-Net-Revenue-of-1-4-Billion-Net-Income-of-241-Million-and-Raises-Full-Year-Guidance/default.aspx",
        "source": "investors.sofi.com",
        "date": "Tue, 27 Oct 2026 10:00:00 GMT",
        "tickers": [],
        "iso": "2026-10-27T10:00:00.000Z"
      },
      {
        "title": "Eli Lilly and Company (NYSE:LLY) Extends Clinical Evidence as Medicine Sales Support Higher Guidance",
        "url": "https://kalkine.com.au/news/healthcare/eli-lilly-and-company-nyselly-extends-clinical-evidence-as-medicine-sales-support-higher-guidance",
        "source": "Kalkine",
        "date": "2026-10-27T06:36:00+00:00",
        "tickers": [
          "LLY"
        ],
        "iso": "2026-10-27T06:36:00.000Z"
      },
      {
        "title": "Microsoft's Stock May Fall Sharply Following Quarterly Results (NASDAQ:MSFT)",
        "url": "https://seekingalpha.com/article/4957544-microsofts-stock-may-fall-sharply-following-quarterly-results",
        "source": "Seeking Alpha",
        "date": "2026-10-26T17:06:07+00:00",
        "tickers": [
          "MSFT"
        ],
        "iso": "2026-10-26T17:06:07.000Z"
      },
      {
        "title": "UnitedHealth Group (NYSE:UNH) Margin Repair Drives Third Guidance Raise as Medical Costs Ease",
        "url": "https://kalkinemedia.com/us/stocks/healthcare/unitedhealth-group-nyseunh-margin-repair-drives-third-guidance-raise-as-medical-costs-ease",
        "source": "Kalkine Media",
        "date": "2026-10-26T13:33:00+00:00",
        "tickers": [
          "UNH"
        ],
        "iso": "2026-10-26T13:33:00.000Z"
      }
    ]
  },
  "analysis_md": "Microsoft reports fiscal first-quarter results after the close on Oct. 28 under a new two-segment structure, with Wall Street expecting EPS of $4.27 on revenue of $90.6 billion.\n## Microsoft Q1 report brings new segments and first Azure revenue figure\nMicrosoft reports fiscal first-quarter results after the bell on Oct. 28, its first under a two-segment structure: Agents and Infra, and Devices and Consumer. It will also give quarterly dollar revenue for Azure for the first time. Bloomberg consensus is EPS of $4.27 on revenue of $90.6 billion, against $4.13 and $77.6 billion a year earlier. Agents and Infra is expected to rise 22.5% to $75.6 billion, with Azure at $32.2 billion. Devices and Consumer is seen down 6% to $15 billion. Capex is expected above $45.9 billion, and remaining performance obligations at $705.6 billion. Microsoft also offered buyouts to upward of 60,000 eligible employees. Shares have climbed about 35% since July.\n**Why it matters:** The first Azure dollar figure and AI-driven capex and backlog numbers will test a stock that has rallied sharply since July.\nSources: [Yahoo Finance](https://finance.yahoo.com/technology/article/microsoft-to-report-q1-earnings-with-wall-street-looking-for-further-azure-growth-160835128.html), [MarketWatch](https://www.marketwatch.com/story/microsoft-earnings-will-look-funky-but-an-elusive-number-is-finally-arriving-73236a94), [Seeking Alpha](https://seekingalpha.com/article/4957544-microsofts-stock-may-fall-sharply-following-quarterly-results)\n## Palantir heads into Nov. 2 earnings near highs as Rosenblatt lifts target\nPalantir reports third-quarter results on Nov. 2 after the close. Analysts estimate EPS of 41 cents on revenue of $2.18 billion, and options pricing implies a 12% move either way. Rosenblatt raised its price target to $260 from $225, implying 31% upside from the Oct. 26 close, citing checks that point to strong growth. LSEG data shows 25 of 34 analysts rate the stock buy or strong buy. In the second quarter, U.S. commercial revenue grew 149% to $764 million, and shares jumped 29.5% after that report. Investors will watch whether full-year guidance, previously raised to 82% revenue growth, goes up again.\n**Why it matters:** A 12% implied move and a stock near its 52-week high leave little room for a guidance disappointment.\nSources: [Investor's Business Daily](https://www.investors.com/research/options/palantir-stock-pltr-software-tech-options-trade-strategy-markets-investing/), [Benzinga](https://www.benzinga.com/trading-ideas/movers/26/10/62617607/palantir-stock-within-7-of-its-52-week-high-as-earnings-and-target-hikes-fuel-buzz), [CNBC](https://www.cnbc.com/2026/10/27/palantir-rosenblatt-price-target-earnings.html)\n## SoFi posts record third quarter and raises 2026 guidance\nSoFi reported third-quarter 2026 results on Oct. 27. Adjusted net revenue rose 44% to a record $1.4 billion, and adjusted EBITDA rose 70% to a record $470 million. Adjusted net income was $243 million, or $0.18 per share. Members grew 35% to 17.1 million, and products rose 44% to 26.7 million. The company lifted 2026 guidance to $5.04 billion in adjusted net revenue and $1.66 billion in adjusted EBITDA. It also introduced a 2027 outlook of $6.4 billion in adjusted net revenue, $2.24 billion in adjusted EBITDA and $0.90 of EPS.\n**Why it matters:** A guidance raise plus a first 2027 outlook gives investors a multi-year earnings path for the fintech lender.\nSources: [investors.sofi.com](https://investors.sofi.com/news/news-details/2026/SoFi-Reports-Third-Quarter-2026-with-Record-Net-Revenue-of-1-4-Billion-Net-Income-of-241-Million-and-Raises-Full-Year-Guidance/default.aspx)\n## Big pharma earnings week: Lilly, Merck, AbbVie, Gilead and Bristol Myers\nBristol Myers, Eli Lilly, Merck, AbbVie and Gilead Sciences are all scheduled to report quarterly results this week. As of Oct. 21, 11.7% of Medical sector companies had reported, and 85.7% of them topped earnings and sales estimates. Sector third-quarter earnings are projected to fall 1.3% while sales rise 4.5%. Bristol Myers' consensus is $12.56 billion in sales and $1.28 per share. Lilly declared a fourth-quarter dividend of $1.73 per share on Oct. 26 and closed at $1,279.14; its second-quarter revenue rose 48%, and management had raised annual revenue guidance.\n**Why it matters:** Results from these bellwethers will shape the sector's earnings picture, with Lilly's volume-driven growth and guidance in focus.\nSources: [TradingView](https://www.tradingview.com/news/zacks:3d4542e71094b:0-what-s-in-store-for-these-5-drug-biotech-stocks-in-q3-earnings/), [Kalkine](https://kalkine.com.au/news/healthcare/eli-lilly-and-company-nyselly-extends-clinical-evidence-as-medicine-sales-support-higher-guidance)\n## UnitedHealth raises guidance a third time as medical costs ease\nUnitedHealth's third-quarter report showed profit rising sharply, adjusted earnings per share well ahead of consensus and another increase to full-year guidance, the third of the year. Revenue was roughly flat from a year earlier as the insurer shed less profitable members. The medical care ratio improved meaningfully, helped by pricing discipline and benefit design changes, though analysts note a reserve release flattered the headline figure. The operating cost ratio also declined. Operating cash flow exceeded net income.\n**Why it matters:** Margin repair at the largest U.S. health insurer signals easing cost pressure, though reserve releases mean underlying gains are smaller than reported.\nSources: [Kalkine Media](https://kalkinemedia.com/us/stocks/healthcare/unitedhealth-group-nyseunh-margin-repair-drives-third-guidance-raise-as-medical-costs-ease)\n## Data behind the stories\n\nAhead of the Oct. 28 report, MSFT closed at $532.6 on Oct. 26, up 1.54% on the day and 3.18% over about a month. PLTR closed at $198.84, up 1.06%, and LLY at $1,279, up 0.45%. UNH closed at $410.7, down 1.77% on the day but up 9.06% over about a month.\n\n- UNH: +9.06% (~1-month)\n- LLY: +8.08% (~1-month)\n- PLTR: +4.83% (~1-month)\n- MSFT: +3.18% (~1-month)\n- JPM: -2.63% (~1-month)\n- GS: -4.51% (~1-month)\n- SOFI: -12.79% (~1-month)\n\n## What to watch\n\n- Microsoft reports fiscal first-quarter results after the market close on Oct. 28, including its first quarterly Azure revenue figure.\n- Palantir reports third-quarter results on Nov. 2 after the close; options imply a 12% move in either direction.\n- Conduent reports third-quarter 2026 results on Nov. 5 after market close, with a conference call at 4:30 p.m. ET.\n\n## Key takeaways\n\n- Microsoft's Oct. 28 report brings new segments, a first Azure dollar figure, and consensus EPS of $4.27 on $90.6 billion revenue.\n- Palantir's Nov. 2 report carries an options-implied 12% move, with Rosenblatt at a $260 target.\n- SoFi raised 2026 guidance to $5.04 billion adjusted net revenue and issued a 2027 outlook.\n\n## FAQ\n\n**When does Microsoft report earnings and what is expected?**\nMicrosoft reports fiscal first-quarter results after the close on Oct. 28. Bloomberg consensus calls for EPS of $4.27 on revenue of $90.6 billion, versus $4.13 and $77.6 billion a year earlier.\n\n**What is new in Microsoft's reporting this quarter?**\nMicrosoft moves to two segments, Agents and Infra, and Devices and Consumer, and will disclose quarterly dollar revenue for Azure for the first time. Azure is expected at $32.2 billion.\n\n**When does Palantir report and how much move is priced in?**\nPalantir reports third-quarter results on Nov. 2 after the market close. Options are pricing in a 12% move in either direction, and analysts estimate EPS of 41 cents on $2.18 billion revenue.\n",
  "sources": [
    {
      "title": "Microsoft to report Q1 earnings with Wall Street looking for further Azure growth",
      "url": "https://finance.yahoo.com/technology/article/microsoft-to-report-q1-earnings-with-wall-street-looking-for-further-azure-growth-160835128.html"
    },
    {
      "title": "Microsoft earnings will look funky — but an elusive number is finally arriving",
      "url": "https://www.marketwatch.com/story/microsoft-earnings-will-look-funky-but-an-elusive-number-is-finally-arriving-73236a94"
    },
    {
      "title": "Microsoft's Stock May Fall Sharply Following Quarterly Results (NASDAQ:MSFT)",
      "url": "https://seekingalpha.com/article/4957544-microsofts-stock-may-fall-sharply-following-quarterly-results"
    },
    {
      "title": "Palantir Put Strategy Aims To Cash In On Potential Earnings Volatility",
      "url": "https://www.investors.com/research/options/palantir-stock-pltr-software-tech-options-trade-strategy-markets-investing/"
    },
    {
      "title": "Palantir Stock Within 7% of Its 52-Week High as Earnings and Target Hikes Fuel Buzz",
      "url": "https://www.benzinga.com/trading-ideas/movers/26/10/62617607/palantir-stock-within-7-of-its-52-week-high-as-earnings-and-target-hikes-fuel-buzz"
    },
    {
      "title": "Buy Palantir ahead of earnings, says Rosenblatt",
      "url": "https://www.cnbc.com/2026/10/27/palantir-rosenblatt-price-target-earnings.html"
    },
    {
      "title": "SoFi Technologies, Inc. (SOFI) - SoFi Reports Third Quarter 2026 with Record Net Revenue of $1.4 Billion, Net Income of $241 Million and Raises Full-Year Guidance",
      "url": "https://investors.sofi.com/news/news-details/2026/SoFi-Reports-Third-Quarter-2026-with-Record-Net-Revenue-of-1-4-Billion-Net-Income-of-241-Million-and-Raises-Full-Year-Guidance/default.aspx"
    },
    {
      "title": "What's in Store for These 5 Drug/Biotech Stocks in Q3 Earnings?",
      "url": "https://www.tradingview.com/news/zacks:3d4542e71094b:0-what-s-in-store-for-these-5-drug-biotech-stocks-in-q3-earnings/"
    },
    {
      "title": "Eli Lilly and Company (NYSE:LLY) Extends Clinical Evidence as Medicine Sales Support Higher Guidance",
      "url": "https://kalkine.com.au/news/healthcare/eli-lilly-and-company-nyselly-extends-clinical-evidence-as-medicine-sales-support-higher-guidance"
    },
    {
      "title": "UnitedHealth Group (NYSE:UNH) Margin Repair Drives Third Guidance Raise as Medical Costs Ease",
      "url": "https://kalkinemedia.com/us/stocks/healthcare/unitedhealth-group-nyseunh-margin-repair-drives-third-guidance-raise-as-medical-costs-ease"
    }
  ],
  "related": [
    {
      "name": "AI & Compute: Broadcom Unveils $63 Billion Financing for Anthropic as AI Stocks Extend Rally",
      "url": "https://agentflare.org/news/2026-10-28-ai.html"
    },
    {
      "name": "Crypto: Bitcoin Recovers Above $80,000 as Galaxy Calls Bear Market Over, Whales Turn Cautious",
      "url": "https://agentflare.org/news/2026-10-28-crypto.html"
    },
    {
      "name": "Macro & Fed: Fed expected to hold at 3.75% to 4% on Oct. 28 as Warsh faces inflation questions",
      "url": "https://agentflare.org/news/2026-10-28-macro.html"
    },
    {
      "name": "Markets: Chip rally lifts Nasdaq 100 to best session in over a month ahead of Fed decision",
      "url": "https://agentflare.org/news/2026-10-28-markets.html"
    }
  ],
  "pricing": {
    "price_usd": 0.005,
    "method": "402",
    "endpoint": "https://esa.aisa.one/api/v1/access/verify",
    "autopay_hint": "set crawlerAutoPrice=true with the X-Crawler-Token header",
    "onboarding": "https://esa.aisa.one/agent/guide.html"
  },
  "powered_by": "AISA — agent-native search, settlement & delivery (https://aisa.one)"
}